Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic NDC 0942-9201

NDC codes

FDA NDC Directory

Product NDC (as listed)0942-9201Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00942-9201Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0942-9201-01	00942920101	35 mL in 1 BAG (0942-9201-01)Marketed from Mar 1, 2007

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic
Generic name (nonproprietary): anticoagulant citrate phosphate dextrose (cpd) solution
Active ingredients: Trisodium citrate dihydrate — 921 mg/35mLDextrose monohydrate — 893 mg/35mLAnhydrous citric acid — 105 mg/35mLSodium phosphate, Monobasic, Monohydrate — 78 mg/35mL
Dosage form: Solution
Route: Intravenous
Labeler: Fenwal, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication BN 170401
Marketing start: Mar 1, 2007
Listing expires: Dec 31, 2026
Other FDA classes: Acidifying Activity (Mechanism)Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)Decreased Coagulation Factor Activity (Physiologic effect)
Identifiers: Product ID 0942-9201_1ee1e424-2028-4b58-b554-883d2e359c28SPL ID 1ee1e424-2028-4b58-b554-883d2e359c28SPL set ID d55cb701-9664-4931-8754-1a8cae68da06UNII B22547B95K, LX22YL083G, XF417D3PSL, 593YOG76RN
Pharmacologic class: Anti-coagulant; Calculi Dissolution Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400942920101 followed by a unit qualifier and the quantity

Package 00942-9201-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 1, 2022.

Full label on DailyMed (opens in a new tab)

Other NDCs under BN 170401

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BN 170401
Product	Strength	Form · route	Labeler	Product NDC
Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plasticanticoagulant citrate phosphate dextrose (cpd)	Trisodium citrate dihydrate 1.66 g/63mL + 3 more ingredients	SolutionIntravenous	Fenwal, Inc.	0942-9202